Study of Utilization of Antiplatelet Agents in Coronary Heart Disease Patients in Private Hospital in Surabaya

Rochmawati, Ike Dhiah and Arifin, Zakiah Rizka Rachmadania (2020) Study of Utilization of Antiplatelet Agents in Coronary Heart Disease Patients in Private Hospital in Surabaya. Jurnal Pharmascience, 7 (1). pp. 99-106. ISSN -Print. 2355-5386; ISSN-Online. 2460-9560

PDF Ike Dhiah Rochmawati_Study of Utilization of Antiplatelet Agents.pdf Download (1MB)

Abstract

Antiplatelet is the most commonly drug used as secondary prevention for Coronary Heart Disease (CHD). The aim of this study was to determine the profile of the use of antiplatelet related with its efficacy and side effects. Observational methods with cross sectional approach for 3 months follow up was used, a descriptive analysis carried out at the private hospital in Surabaya. Results from this study: aspirin 80 mg was the most prescribed antiplatelet in patients with the incidence of ischemic events 9%. Higher ischemic events also seen in patients with hypertension, dyslipidemia, and Diabetes Mellitus. Bleeding and gastrointestinal disturbance as side effects occurred in 4 patients who used aspirin as antiplatelet, and based for Naranjo scale can be concluded as possible adverse drug reaction.

Item Type:	Article
Uncontrolled Keywords:	Coronary Heart Disease, Antiplatelet , Ischemic events, Bleeding
Subjects:	R Medicine > RS Pharmacy and materia medica
Divisions:	Faculty of Pharmacy > Department of Pharmacy
Depositing User:	Ester Sri W. 196039
Date Deposited:	30 Jul 2021 07:10
Last Modified:	20 Sep 2021 06:18
URI:	http://repository.ubaya.ac.id/id/eprint/39884

Actions (login required)

View Item